United States · FDA National Drug Code directory
ZARXIO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61314-326_f213544a-940c-4fd3-b769-d227ff6b76d0
- Product NDC
- 61314-326
- Form
- INJECTION, SOLUTION
- Composition / generic term
- filgrastim-sndz
- Labeler
- Sandoz Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20150306
- Source listing expiry
- 20271231
Source-listed ingredients
- FILGRASTIM — 480 ug/.8mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (61314-326-01) / 1 SYRINGE in 1 BLISTER PACK / .8 mL in 1 SYRINGE · 61314-326-01
- 2 BLISTER PACK in 1 CARTON (61314-326-10) / 5 SYRINGE in 1 BLISTER PACK (61314-326-05) / .8 mL in 1 SYRINGE · 61314-326-10
- 1 BLISTER PACK in 1 CARTON (61314-326-63) / 1 SYRINGE in 1 BLISTER PACK / .8 mL in 1 SYRINGE · 61314-326-63
- 2 BLISTER PACK in 1 CARTON (61314-326-69) / 5 SYRINGE in 1 BLISTER PACK (61314-326-65) / .8 mL in 1 SYRINGE · 61314-326-69
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →